Spiderwort Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 18

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 21

Spiderwort General Information

Description

Developer of transformative biomaterials designed to repair and regenerate human tissue. The company uses cellulose-based biomaterials to engineer living scaffolds for groundbreaking regenerative medicine applications, helping regrow body parts with plant-like tissues rather than synthetic materials for spinal cord injury repair and soft tissue regeneration, enabling the healthcare industry to promote the repair and regeneration of living tissues, including the spinal cord.

Contact Information

Website
www.spiderwortbio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 7 Bayview Station Road
  • Ottawa, Ontario K1Y 2C5
  • Canada
Primary Industry
Biotechnology
Other Industries
Other Healthcare Services
Therapeutic Devices
Medical Supplies
Vertical(s)
Digital Health, Life Sciences
Corporate Office
  • 7 Bayview Station Road
  • Ottawa, Ontario K1Y 2C5
  • Canada

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Spiderwort Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Accelerator/Incubator 22-Nov-2023 Completed Pre-Clinical Trials
11. Accelerator/Incubator 06-Jun-2023 Completed Pre-Clinical Trials
10. Later Stage VC (Series A) 16-Mar-2022 Completed Pre-Clinical Trials
9. Later Stage VC (Series A) 12-Nov-2020 Cancelled Pre-Clinical Trials
8. Seed Round 27-May-2020 Completed Pre-Clinical Trials
7. Angel (individual) 31-Aug-2018 Completed Pre-Clinical Trials
6. Accelerator/Incubator Completed Pre-Clinical Trials
5. Accelerator/Incubator 01-Jan-2018 Completed Pre-Clinical Trials
4. Grant 21-Jun-2017 $37.3K $15.7K Completed Pre-Clinical Trials
3. Accelerator/Incubator $15.7K Completed Startup
To view Spiderwort’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Spiderwort Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of transformative biomaterials designed to repair and regenerate human tissue. The company uses cellulose-base
Biotechnology
Ottawa, Canada
18 As of 2026

Lake Forest, CA
 

Misgav, Israel
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Spiderwort Competitors (25)

One of Spiderwort’s 25 competitors is Harbor MedTech, a Formerly VC-backed company based in Lake Forest, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Harbor MedTech Formerly VC-backed Lake Forest, CA
CoreBone Venture Capital-Backed Misgav, Israel
Asymmetrex Corporation Boston, MA
Sofregen Venture Capital-Backed Framingham, MA
NOVADIP Venture Capital-Backed Mont-Saint-Guibert, Belgium
You’re viewing 5 of 25 competitors. Get the full list »

Spiderwort Patents

  • 37

    Total Documents Applications and Grants

  • Total Patents Families

  • 7

    Granted

  • 19

    Pending

  • Expiring in next 12 mo

Spiderwort Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2024254696-A1 Plant-based scaffolds and tunable hydrogels for bioprinting and methods thereof Inactive 13-Jun-2023
US-20250375571-A1 Methods and devices for removing agglomerations from of a viscous material Pending 27-Oct-2022
WO-2024086948-A1 Methods and devices for removing agglomerations from of a viscous material Inactive 27-Oct-2022
AU-2022320142-A1 Methods for rapidly infiltrating 3d scaffolds with cells Inactive 30-Jul-2021
CA-3227241-A1 Methods for rapidly infiltrating 3d scaffolds with cells Pending 30-Jul-2021 C12N5/0658
To view Spiderwort’s complete patent history, request access »

Spiderwort Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Spiderwort Investors (21)

Investor Name Investor Type Holding Investor Since Participating Rounds
Canadian Entrepreneurs in Life Science Accelerator/Incubator
MaRS Investment Accelerator Fund Venture Capital Minority
K5 Global Venture Capital Minority
Praxis Spinal Cord Institute Accelerator/Incubator Minority
Ventured Synergy Venture Capital Minority
You’re viewing 5 of 21 investors. Get the full list »

Ready to get started?

Request a free trial

Spiderwort FAQs

  • When was Spiderwort founded?

    Spiderwort was founded in 2015.

  • Where is Spiderwort headquartered?

    Spiderwort is headquartered in Ottawa, Canada.

  • What is the size of Spiderwort?

    Spiderwort has 18 total employees.

  • What industry is Spiderwort in?

    Spiderwort’s primary industry is Biotechnology.

  • Is Spiderwort a private or public company?

    Spiderwort is a Private company.

  • What is Spiderwort’s current revenue?

    The current revenue for Spiderwort is .

  • How much funding has Spiderwort raised over time?

    Spiderwort has raised $15.6M.

  • Who are Spiderwort’s investors?

    Canadian Entrepreneurs in Life Science, MaRS Investment Accelerator Fund, K5 Global, Praxis Spinal Cord Institute, and Ventured Synergy are 5 of 21 investors who have invested in Spiderwort.

  • Who are Spiderwort’s competitors?

    Harbor MedTech, CoreBone, Asymmetrex, Sofregen, and NOVADIP are some of the 25 competitors of Spiderwort.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process